Types of Myopia Control
MiyoSmart Spectacle Lenses
Hoya’s MiyoSmart Spectacle Lenses are eyeglass lenses specially designed for myopia control. The innovative lenses have been shown to curb myopia progression in children by 60% through its award-winning defocus incorporated multiple segments technology (D.I.M.S.).
The lenses are also designed to suit a typical child’s active lifestyle. They are made from polycarbonate 1.59, a highly impact-resistant material that has passed the high-velocity impact drop ball test.
MyoVision Pro Spectacle Lenses
ZEISS’ MyoVision Pro lenses are another style of lenses specifically designed to slow the progression of myopia. The lenses apply peripheral defocus management principles to send signals to the eye to stop it from growing too long.
The lenses are specially designed for children to complement their growing eyes and lifestyle while simultaneously slowing myopia’s development.
Multifocal Contact Lenses
Several studies performed in the early 2010s have shown that multifocal contact lenses can effectively slow myopia’s progression in children.
Multifocal contact lenses have a center distance design that mimics a bullseye. There are 2 portions for focusing light, with the center portion correcting nearsightedness, so light focuses directly on the retina. The surrounding portion adds focusing power that brings peripheral light rays to focus in front of the retina.
Studies have shown that bringing light to focus in front of the retina cues the eye to stop growing, which will curb the progression of myopia.
Orthokeratology
Orthokeratology, or Ortho-K lenses, are specially designed contact lenses that are worn overnight to reshape the cornea. The lenses apply gentle pressure to “mold” the cornea’s outer layers when worn overnight. When the lenses are removed during the day, you will be able to enjoy clear vision without the need for glasses or contact lenses.
Orthokeratology has many peer-reviewed, randomized, and longitudinal studies that show it is an effective method to reduce myopia’s progression.